Researchers take a step toward universal flu vaccine
Wednesday, June 30, 2010 - 08:49
in Health & Medicine
Researchers at a small Seattle biotech company, Theraclone, have discovered rare anti-flu antibodies that target a potential vulnerability in flu viruses.